Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in New Mexico 2026: $69 a month, plus yearly membership

By John Samaras, price analyst · Prices checked Nov 16, 2026

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to New Mexico from $69 a month at Collective, plus a yearly membership, the lowest of the programs we track, read on November 16, 2026. New Mexico Medicaid does not cover Zepbound for weight loss.

Paying cash for compounded tirzepatide in New Mexico

Eden logo

Weight loss or money back Eden

compounded tirzepatide
$129/mo

Includes medication, provider review and shipping

Ships to New Mexico. Same price at every dose.

Collective logo

Lowest monthly drug price Collective

compounded tirzepatide
$69/mo

Ships to New Mexico. Same price at every dose.

Some links earn us a commission.

Who ships compounded tirzepatide to New Mexico

  1. Collective: $69 a month
  2. Eden: $129 a month
  3. CoreAge Rx: $129 a month
  4. Embody: $129 a month
  5. SnagRx: $149 a month

Every program on our compounded tirzepatide chart ships to New Mexico. The full chart has every price.

Does New Mexico Medicaid cover Zepbound?

New Mexico Medicaid does not cover Zepbound for weight loss. New Mexico Medicaid plans include Blue Cross Blue Shield of New Mexico, Molina Healthcare of New Mexico, Presbyterian Health Plan and Western Sky Community Care (Centene).

New Mexico Turquoise Care MCOs follow the state PDL exclusion of weight-loss GLP-1. The state PDL committee has reviewed the question but has not added obesity coverage. Diabetes coverage with PA is standard.

The New Mexico Medicaid drug list was last reviewed in the third quarter of 2025. New Mexico Medicaid GLP-1 rules.

GLP-1 prescriptions New Mexico Medicaid paid for

QuarterPrescriptionsMedicaid paidPer prescription
Apr to Jun 202514,580$14.7 million$1,010
Jul to Sep 202515,443$15.6 million$1,010
Oct to Dec 202514,610$14.5 million$990
Jan to Mar 202615,350$15.3 million$1,000

New Mexico Medicaid paid for 15,350 GLP-1 prescriptions in the first quarter of 2026, up 5% from 14,580 in the second quarter of 2025.

Source: CMS State Drug Utilization Data, all GLP-1 brands, before rebates.

Obesity and insurance in New Mexico

35.3% of adults in New Mexico had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. 15.6% of New Mexico residents have no health insurance and 16.9% live below the poverty line (Census SAIPE 2023). Of the largest counties, McKinley County has the highest adult obesity rate, 41.3% (CDC PLACES 2025).

CountyAdults with obesityNo health insuranceBelow the poverty line
Bernalillo County33.0%14.0%13.5%
Doña Ana County35.9%19.7%19.8%
San Juan County35.1%12.9%19.9%
McKinley County41.3%15.1%34.3%
Sandoval County32.6%12.3%11.7%
Santa Fe County25.6%13.1%12.2%
Otero County37.1%15.7%19.4%
Chaves County39.8%20.2%20.1%
Valencia County35.4%18.6%17.3%
Lea County37.0%21.6%17.0%

Source: CDC PLACES 2025 for obesity, Census SAIPE 2023 for insurance and poverty.

More for New Mexico

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.